Inductions of germ tube and hyphal formations are controlled by mRNA synthesis inhibitor in Candida albicans

Japanese Journal of Medical Mycology

Volumn 45, Issue 2, 2004, Pages 113-119

  Imanishi, Yumi ^b   Yokoyama, Koji ^a   Nishimura, Kazuko ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NITE Biological Resource Center (NBRC)   (Japan)

Author keywords

Candida albicans; Germ tube; MRNA synthesis inhibitor; Serum

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; HYDROXYUREA; MESSENGER RNA; MESSENGER RNA SYNTHESIS INHIBITOR; PROTEIN; PROTEIN SYNTHESIS INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CELL BUDDING; CONTROLLED STUDY; CULTURE MEDIUM; FUNGAL FILAMENTATION; FUNGAL GENE; FUNGAL MORPHOLOGY; FUNGAL SPORE GERMINATION; FUNGUS GROWTH; FUNGUS HYPHAE; GERM TUBE; HFM7 MEDIUM; MESSENGER RNA SYNTHESIS; NONHUMAN; PROTEIN SYNTHESIS; SERUM; YEAST CELL; YPD MEDIUM;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 2442720025     PISSN: 09164804     EISSN: None     Source Type: Journal    
DOI: 10.3314/jjmm.45.113     Document Type: Article

References (15)

1. Odds FC: Pathogenesis of Candida infections. J Am Acad Dermatol 31: S2-5, 1994.
2. Leberer E, Ziegelbauer K, Schmidt A, Harcus D, Dignard D, Ash J, Johnson L, Thomas DY: Virulence and hyphal formation of Candida albicans require the Ste20p-like protein kinase CaCla4p. Curr Biol 7: 539-546, 1997.
3. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR: Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949, 1997.
4. Gale CA, Bendel CM, McClellan M, Hauser M, Becker JM, Berman J, Hostetter MK: Linkage of adhesion, filamentous growth, and virulence in Candida albicans to single gene, INT1. Science 279: 1355-1358, 1998.
5. Hazan I, Sepulveda-Becerra M, Liu H: Hyphal elongation is regulated independently of cell cycle in Candida albicans. Mol Biol Cell 13: 134-145, 2002.
6. Shepherd MG, Yin CY, Ram SP, Sullivan PA: Germ tube induction in Candida albicans. Can J Microbiol 26: 21-26, 1980.
7. Land GA, Hulme KL, Chaffin WL: The effect of selected antineoplastic agents on the morphology of Candida albicans 5865. Can J Microbiol 26: 812-818, 1980.
8. Lee KL, Buckley HR, Campbell CC: An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia 13: 148-153, 1975.
9. Buchan ADB, Gow AR: Rates of germ tube formation from growing and non-growing yeast cells of Candida albicans. FEMS Microbiol Lett 81: 15-18, 1991.
10. Santiago TC, Purvis IJ, Bettany AJE, Brown AJP: The relationship between mRNA stability and length in Saccharomyces cerevisiae. Nucleic Acids Res 14: 8347-8360, 1986.
11. Mitchell AP: Dimorphism and virulence in Candida albicans. Curr Opin Microbiol 1: 687-692, 1998.
12. Ernst JF: Transcription factors in Candida albicans-environmental control of morphogenesis. Microbiol 146: 1763-1774, 2000.
13. Koç A, Wheeler LJ, Mathews CK, Merrill GF: Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools. J Biol Chem published October 21, 2003
14. Bailey DA, Feldmann PJF, Bovey M, Gow NAR, Brown AJP: The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J Bacteriol 178: 5353-5360, 1996.
15. Munro CA, Schofield DA, Gooday GW, Gow NAR: Regulation of chitin synthesis during dimorphic growth of Candida albicans. Microbiol 144: 391-401, 1998.